Delivery Order SPE2DB20D3104-SPE2DB25FV9R2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,924.44 with a firm fixed price structure and an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,006.30 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. Performance of this delivery order will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract is a child order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count package) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,270.22 and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,808.62. This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a child delivery order executed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $5,114.14 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order was executed on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract carries no set-aside designation and represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government....
- The Defense Logistics Agency awarded a delivery order valued at $1,258.98 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Telmisartan 80 mg tablets (30-count units) under a firm fixed-price contract valued at $4,706.88. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 11, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Telmisartan 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,555.12. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,093.50 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count packaging) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9R2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,849.20 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Telmisartan 80 mg tablets in quantities of 30. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is expected to reach ultimate completion by August 20, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen Drug Corp has demonstrated substantial capability in meeting federal medical procurement requirements through open competition, with its federal contract portfolio encompassing diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/19/25 |